Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Druzhestven N IzsledovatelskifiledCriticalDruzhestven N Izsledovatelski
Priority to BG9079389ApriorityCriticalpatent/BG49852A1/en
Publication of BG49852A1publicationCriticalpatent/BG49852A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
The medicinal form ensures a thorough wetting of the treated surfaces and a high therapeutical effect for the constituent medicinal substances. The form contains, in percent (w/w): 85-95 liquid glycols, 3.5-4.5 surface-active agent, 0.5-0.6 absolute ethyl alcohol, 9-11 propellant and 0.5-1.5 active substance. The surface-active agent is polyoxyethylen-10-stearylether and the propellant is dichlorodifluoromethane.
BG9079389A1989-12-291989-12-29Local medicine form
BG49852A1
(en)
An aromatase-inhibitor for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations suitable for such a use.
Process for the production of medical preparations for preventing proline-and lysine-hydroxylase and process for the production of some of the active agents
New therapeutical antiphlogistic and analgetic pharmaceutical composition containing nimesulid (4-nitro, 2-phenoxyphenylmethanesulphonamide) for subcutaneous application and method for its preparation